Global Lysosomal Storage Diseases Therapeutics Market Research Report 2023

Lysosomal storage disorders is a group of genetic metabolic diseases caused by enzyme deficiencies in various body cells.

The global Lysosomal Storage Diseases Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The Gaucher's Diseases indication segment is expected to be the most dominant segment in global lysosomal storage diseases therapeutics market.

This report aims to provide a comprehensive presentation of the global market for Lysosomal Storage Diseases Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lysosomal Storage Diseases Therapeutics.

The Lysosomal Storage Diseases Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Lysosomal Storage Diseases Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lysosomal Storage Diseases Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lysosomal Storage Diseases Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Enzyme Replacement Therapy

1.2.3 Stem Cell Therapy

1.2.4 Substrate Reduction Therapy

1.2.5 Others

1.3 Market by Application

1.3.1 Global Lysosomal Storage Diseases Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Lysosomal Storage Diseases Therapeutics Market Perspective (2018-2029)

2.2 Lysosomal Storage Diseases Therapeutics Growth Trends by Region

2.2.1 Global Lysosomal Storage Diseases Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Lysosomal Storage Diseases Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 Lysosomal Storage Diseases Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 Lysosomal Storage Diseases Therapeutics Market Dynamics

2.3.1 Lysosomal Storage Diseases Therapeutics Industry Trends

2.3.2 Lysosomal Storage Diseases Therapeutics Market Drivers

2.3.3 Lysosomal Storage Diseases Therapeutics Market Challenges

2.3.4 Lysosomal Storage Diseases Therapeutics Market Restraints

3.1 Global Top Lysosomal Storage Diseases Therapeutics Players by Revenue

3.1.1 Global Top Lysosomal Storage Diseases Therapeutics Players by Revenue (2018-2023)

3.1.2 Global Lysosomal Storage Diseases Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global Lysosomal Storage Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Lysosomal Storage Diseases Therapeutics Revenue

3.4 Global Lysosomal Storage Diseases Therapeutics Market Concentration Ratio

3.4.1 Global Lysosomal Storage Diseases Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lysosomal Storage Diseases Therapeutics Revenue in 2022

3.5 Lysosomal Storage Diseases Therapeutics Key Players Head office and Area Served

3.6 Key Players Lysosomal Storage Diseases Therapeutics Product Solution and Service

3.7 Date of Enter into Lysosomal Storage Diseases Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Lysosomal Storage Diseases Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global Lysosomal Storage Diseases Therapeutics Forecasted Market Size by Type (2024-2029)

5.1 Global Lysosomal Storage Diseases Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global Lysosomal Storage Diseases Therapeutics Forecasted Market Size by Application (2024-2029)

6.1 North America Lysosomal Storage Diseases Therapeutics Market Size (2018-2029)

6.2 North America Lysosomal Storage Diseases Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Lysosomal Storage Diseases Therapeutics Market Size by Country (2018-2023)

6.4 North America Lysosomal Storage Diseases Therapeutics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Lysosomal Storage Diseases Therapeutics Market Size (2018-2029)

7.2 Europe Lysosomal Storage Diseases Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Lysosomal Storage Diseases Therapeutics Market Size by Country (2018-2023)

7.4 Europe Lysosomal Storage Diseases Therapeutics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Lysosomal Storage Diseases Therapeutics Market Size (2018-2029)

8.2 Asia-Pacific Lysosomal Storage Diseases Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Lysosomal Storage Diseases Therapeutics Market Size by Region (2018-2023)

8.4 Asia-Pacific Lysosomal Storage Diseases Therapeutics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Lysosomal Storage Diseases Therapeutics Market Size (2018-2029)

9.2 Latin America Lysosomal Storage Diseases Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Lysosomal Storage Diseases Therapeutics Market Size by Country (2018-2023)

9.4 Latin America Lysosomal Storage Diseases Therapeutics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Lysosomal Storage Diseases Therapeutics Market Size (2018-2029)

10.2 Middle East & Africa Lysosomal Storage Diseases Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Lysosomal Storage Diseases Therapeutics Market Size by Country (2018-2023)

10.4 Middle East & Africa Lysosomal Storage Diseases Therapeutics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Takeda

11.1.1 Takeda Company Detail

11.1.2 Takeda Business Overview

11.1.3 Takeda Lysosomal Storage Diseases Therapeutics Introduction

11.1.4 Takeda Revenue in Lysosomal Storage Diseases Therapeutics Business (2018-2023)

11.1.5 Takeda Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Detail

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Lysosomal Storage Diseases Therapeutics Introduction

11.2.4 Pfizer Revenue in Lysosomal Storage Diseases Therapeutics Business (2018-2023)

11.2.5 Pfizer Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Detail

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Lysosomal Storage Diseases Therapeutics Introduction

11.3.4 Sanofi Revenue in Lysosomal Storage Diseases Therapeutics Business (2018-2023)

11.3.5 Sanofi Recent Development

11.4 BioMarin Pharmaceutical

11.4.1 BioMarin Pharmaceutical Company Detail

11.4.2 BioMarin Pharmaceutical Business Overview

11.4.3 BioMarin Pharmaceutical Lysosomal Storage Diseases Therapeutics Introduction

11.4.4 BioMarin Pharmaceutical Revenue in Lysosomal Storage Diseases Therapeutics Business (2018-2023)

11.4.5 BioMarin Pharmaceutical Recent Development

11.5 Actelion Ltd

11.5.1 Actelion Ltd Company Detail

11.5.2 Actelion Ltd Business Overview

11.5.3 Actelion Ltd Lysosomal Storage Diseases Therapeutics Introduction

11.5.4 Actelion Ltd Revenue in Lysosomal Storage Diseases Therapeutics Business (2018-2023)

11.5.5 Actelion Ltd Recent Development

11.6 Raptor Pharmaceutical

11.6.1 Raptor Pharmaceutical Company Detail

11.6.2 Raptor Pharmaceutical Business Overview

11.6.3 Raptor Pharmaceutical Lysosomal Storage Diseases Therapeutics Introduction

11.6.4 Raptor Pharmaceutical Revenue in Lysosomal Storage Diseases Therapeutics Business (2018-2023)

11.6.5 Raptor Pharmaceutical Recent Development

11.7 Protalix BiOthersapeutics

11.7.1 Protalix BiOthersapeutics Company Detail

11.7.2 Protalix BiOthersapeutics Business Overview

11.7.3 Protalix BiOthersapeutics Lysosomal Storage Diseases Therapeutics Introduction

11.7.4 Protalix BiOthersapeutics Revenue in Lysosomal Storage Diseases Therapeutics Business (2018-2023)

11.7.5 Protalix BiOthersapeutics Recent Development

11.8 Amicus Therapeutics

11.8.1 Amicus Therapeutics Company Detail

11.8.2 Amicus Therapeutics Business Overview

11.8.3 Amicus Therapeutics Lysosomal Storage Diseases Therapeutics Introduction

11.8.4 Amicus Therapeutics Revenue in Lysosomal Storage Diseases Therapeutics Business (2018-2023)

11.8.5 Amicus Therapeutics Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Lysosomal Storage Diseases Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Enzyme Replacement Therapy

    Table 3. Key Players of Stem Cell Therapy

    Table 4. Key Players of Substrate Reduction Therapy

    Table 5. Key Players of Others

    Table 6. Global Lysosomal Storage Diseases Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Lysosomal Storage Diseases Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Lysosomal Storage Diseases Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Lysosomal Storage Diseases Therapeutics Market Share by Region (2018-2023)

    Table 10. Global Lysosomal Storage Diseases Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Lysosomal Storage Diseases Therapeutics Market Share by Region (2024-2029)

    Table 12. Lysosomal Storage Diseases Therapeutics Market Trends

    Table 13. Lysosomal Storage Diseases Therapeutics Market Drivers

    Table 14. Lysosomal Storage Diseases Therapeutics Market Challenges

    Table 15. Lysosomal Storage Diseases Therapeutics Market Restraints

    Table 16. Global Lysosomal Storage Diseases Therapeutics Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Lysosomal Storage Diseases Therapeutics Market Share by Players (2018-2023)

    Table 18. Global Top Lysosomal Storage Diseases Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Diseases Therapeutics as of 2022)

    Table 19. Ranking of Global Top Lysosomal Storage Diseases Therapeutics Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Lysosomal Storage Diseases Therapeutics Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Lysosomal Storage Diseases Therapeutics Product Solution and Service

    Table 23. Date of Enter into Lysosomal Storage Diseases Therapeutics Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Lysosomal Storage Diseases Therapeutics Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Lysosomal Storage Diseases Therapeutics Revenue Market Share by Type (2018-2023)

    Table 27. Global Lysosomal Storage Diseases Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Lysosomal Storage Diseases Therapeutics Revenue Market Share by Type (2024-2029)

    Table 29. Global Lysosomal Storage Diseases Therapeutics Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Lysosomal Storage Diseases Therapeutics Revenue Market Share by Application (2018-2023)

    Table 31. Global Lysosomal Storage Diseases Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Lysosomal Storage Diseases Therapeutics Revenue Market Share by Application (2024-2029)

    Table 33. North America Lysosomal Storage Diseases Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Lysosomal Storage Diseases Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Lysosomal Storage Diseases Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Lysosomal Storage Diseases Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Lysosomal Storage Diseases Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Lysosomal Storage Diseases Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Lysosomal Storage Diseases Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Lysosomal Storage Diseases Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Lysosomal Storage Diseases Therapeutics Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Lysosomal Storage Diseases Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Lysosomal Storage Diseases Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Lysosomal Storage Diseases Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Lysosomal Storage Diseases Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Lysosomal Storage Diseases Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Lysosomal Storage Diseases Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Takeda Company Detail

    Table 49. Takeda Business Overview

    Table 50. Takeda Lysosomal Storage Diseases Therapeutics Product

    Table 51. Takeda Revenue in Lysosomal Storage Diseases Therapeutics Business (2018-2023) & (US$ Million)

    Table 52. Takeda Recent Development

    Table 53. Pfizer Company Detail

    Table 54. Pfizer Business Overview

    Table 55. Pfizer Lysosomal Storage Diseases Therapeutics Product

    Table 56. Pfizer Revenue in Lysosomal Storage Diseases Therapeutics Business (2018-2023) & (US$ Million)

    Table 57. Pfizer Recent Development

    Table 58. Sanofi Company Detail

    Table 59. Sanofi Business Overview

    Table 60. Sanofi Lysosomal Storage Diseases Therapeutics Product

    Table 61. Sanofi Revenue in Lysosomal Storage Diseases Therapeutics Business (2018-2023) & (US$ Million)

    Table 62. Sanofi Recent Development

    Table 63. BioMarin Pharmaceutical Company Detail

    Table 64. BioMarin Pharmaceutical Business Overview

    Table 65. BioMarin Pharmaceutical Lysosomal Storage Diseases Therapeutics Product

    Table 66. BioMarin Pharmaceutical Revenue in Lysosomal Storage Diseases Therapeutics Business (2018-2023) & (US$ Million)

    Table 67. BioMarin Pharmaceutical Recent Development

    Table 68. Actelion Ltd Company Detail

    Table 69. Actelion Ltd Business Overview

    Table 70. Actelion Ltd Lysosomal Storage Diseases Therapeutics Product

    Table 71. Actelion Ltd Revenue in Lysosomal Storage Diseases Therapeutics Business (2018-2023) & (US$ Million)

    Table 72. Actelion Ltd Recent Development

    Table 73. Raptor Pharmaceutical Company Detail

    Table 74. Raptor Pharmaceutical Business Overview

    Table 75. Raptor Pharmaceutical Lysosomal Storage Diseases Therapeutics Product

    Table 76. Raptor Pharmaceutical Revenue in Lysosomal Storage Diseases Therapeutics Business (2018-2023) & (US$ Million)

    Table 77. Raptor Pharmaceutical Recent Development

    Table 78. Protalix BiOthersapeutics Company Detail

    Table 79. Protalix BiOthersapeutics Business Overview

    Table 80. Protalix BiOthersapeutics Lysosomal Storage Diseases Therapeutics Product

    Table 81. Protalix BiOthersapeutics Revenue in Lysosomal Storage Diseases Therapeutics Business (2018-2023) & (US$ Million)

    Table 82. Protalix BiOthersapeutics Recent Development

    Table 83. Amicus Therapeutics Company Detail

    Table 84. Amicus Therapeutics Business Overview

    Table 85. Amicus Therapeutics Lysosomal Storage Diseases Therapeutics Product

    Table 86. Amicus Therapeutics Revenue in Lysosomal Storage Diseases Therapeutics Business (2018-2023) & (US$ Million)

    Table 87. Amicus Therapeutics Recent Development

    Table 88. Research Programs/Design for This Report

    Table 89. Key Data Information from Secondary Sources

    Table 90. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Lysosomal Storage Diseases Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Lysosomal Storage Diseases Therapeutics Market Share by Type: 2022 VS 2029

    Figure 3. Enzyme Replacement Therapy Features

    Figure 4. Stem Cell Therapy Features

    Figure 5. Substrate Reduction Therapy Features

    Figure 6. Others Features

    Figure 7. Global Lysosomal Storage Diseases Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Lysosomal Storage Diseases Therapeutics Market Share by Application: 2022 VS 2029

    Figure 9. Hospitals Case Studies

    Figure 10. Clinics Case Studies

    Figure 11. Others Case Studies

    Figure 12. Lysosomal Storage Diseases Therapeutics Report Years Considered

    Figure 13. Global Lysosomal Storage Diseases Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Lysosomal Storage Diseases Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Lysosomal Storage Diseases Therapeutics Market Share by Region: 2022 VS 2029

    Figure 16. Global Lysosomal Storage Diseases Therapeutics Market Share by Players in 2022

    Figure 17. Global Top Lysosomal Storage Diseases Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Diseases Therapeutics as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Lysosomal Storage Diseases Therapeutics Revenue in 2022

    Figure 19. North America Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Lysosomal Storage Diseases Therapeutics Market Share by Country (2018-2029)

    Figure 21. United States Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Lysosomal Storage Diseases Therapeutics Market Share by Country (2018-2029)

    Figure 25. Germany Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Lysosomal Storage Diseases Therapeutics Market Share by Region (2018-2029)

    Figure 33. China Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Lysosomal Storage Diseases Therapeutics Market Share by Country (2018-2029)

    Figure 41. Mexico Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Lysosomal Storage Diseases Therapeutics Market Share by Country (2018-2029)

    Figure 45. Turkey Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Lysosomal Storage Diseases Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Takeda Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2018-2023)

    Figure 48. Pfizer Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2018-2023)

    Figure 49. Sanofi Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2018-2023)

    Figure 50. BioMarin Pharmaceutical Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2018-2023)

    Figure 51. Actelion Ltd Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2018-2023)

    Figure 52. Raptor Pharmaceutical Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2018-2023)

    Figure 53. Protalix BiOthersapeutics Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2018-2023)

    Figure 54. Amicus Therapeutics Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2018-2023)

    Figure 55. Bottom-up and Top-down Approaches for This Report

    Figure 56. Data Triangulation

    Figure 57. Key Executives Interviewed